OVERVIEW OF EVIDENCE SUPPORTING TREATMENT OF HYPERLIPIDEMIA. Pre-statin trials. Primary prevention statin trials. Secondary prevention statin trials. Other trials. Normal Lipid Values.- NCEP/ATP-III GUIDELINES. Review of ATP-III for treatment of hyperlipidemia. Review of 2004 ATP-III update. Review of ATP-IV.- LIFESTYLE CHANGES AND NON-DRUG TREATMENT. Weight loss and other diets--benefits and risks. Therapeutic foods. Exercise interventions--benefits and risks.- DRUG TREATMENT. General principles of drug treatment of hyperlipidemia. Agents (action, dosing, side effects, unique uses). Drug interactions. Drug intolerance and severe side effects. Drugs of the future.- SPECIAL POPULATIONS AND SITUATIONS. Elderly patients .-Patients with multiple medical problems. Women. Adults younger than 35 years of age. Children. Elite athletes. Native Americans. Immigrants. Family issues. Community issues and population health concerns.- OTHER ISSUES IN PREVENTION OF CARDIOVASCULAR DISEASE. Aspirin prophylaxis. Novel screening tools for risk assessment.- PRACTICAL APPROACH TO THE PATIENT WITH HYPERLIPIDEMIA. Treatment algorithms. Visit and serum testing frequency. Compliance and motivational tools. Referral guidelines for refractory hyperlipidemia.- CASE STUDIES. The well elderly patient. The well young patient. The diabetic. The patient with intermediate risk. The unreachable goal. Kids. Normal cholesterol, but high TG and low HDL. Can't use statins. Metabolic syndrome.- FUTURE DIRECTIONS. How low do you go? PPARs and prevention of metabolic syndrome. Integrative treatment (diet + exercise + drugs).
EAN/ISBN : 9780387766065
Publisher(s): Springer, Berlin, Springer, New York
Format: ePub/PDF

Author(s): Reamy, Brian V.